$AWRE
AWARE INC /MA/

2022 Q4 Form 10-Q Financial Statement

#000095017022020458 Filed on October 28, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $4.063M $3.015M
YoY Change 1.65% -27.78%
Cost Of Revenue $340.0K $282.0K
YoY Change 22.74% 16.05%
Gross Profit $3.723M $2.733M
YoY Change 0.08% -30.49%
Gross Profit Margin 91.63% 90.65%
Selling, General & Admin $3.441M $3.682M
YoY Change 12.71% 14.88%
% of Gross Profit 92.43% 134.72%
Research & Development $2.302M $2.279M
YoY Change 5.02% -1.21%
% of Gross Profit 61.83% 83.39%
Depreciation & Amortization $173.0K $141.0K
YoY Change 3.59% -17.54%
% of Gross Profit 4.65% 5.16%
Operating Expenses $5.743M $5.961M
YoY Change 9.49% 8.15%
Operating Profit -$2.020M $2.444M
YoY Change 32.46% -254.68%
Interest Expense $311.0K $155.0K
YoY Change 31000.0% 15400.0%
% of Operating Profit 6.34%
Other Income/Expense, Net
YoY Change
Pretax Income -$1.709M $2.599M
YoY Change 12.14% -264.6%
Income Tax $49.00K $0.00
% Of Pretax Income 0.0%
Net Earnings -$1.758M $2.599M
YoY Change 40.08% -264.6%
Net Earnings / Revenue -43.27% 86.2%
Basic Earnings Per Share $0.12
Diluted Earnings Per Share -$0.08 $0.12
COMMON SHARES
Basic Shares Outstanding 21.66M 21.73M
Diluted Shares Outstanding 21.80M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.93M $31.02M
YoY Change -3.45% -6.85%
Cash & Equivalents $11.70M $12.70M
Short-Term Investments $17.23M $18.32M
Other Short-Term Assets $693.0K $1.438M
YoY Change 17.26% 93.02%
Inventory
Prepaid Expenses
Receivables $3.317M $3.664M
Other Receivables $1.362M $1.411M
Total Short-Term Assets $37.28M $41.24M
YoY Change -3.96% -1.45%
LONG-TERM ASSETS
Property, Plant & Equipment $726.0K $208.0K
YoY Change -77.43% -93.76%
Goodwill $3.120M $3.120M
YoY Change 0.0%
Intangibles $2.806M $2.910M
YoY Change -12.91%
Long-Term Investments
YoY Change
Other Assets $122.0K
YoY Change
Total Long-Term Assets $13.91M $8.808M
YoY Change 45.56% 45.11%
TOTAL ASSETS
Total Short-Term Assets $37.28M $41.24M
Total Long-Term Assets $13.91M $8.808M
Total Assets $51.19M $50.05M
YoY Change 5.83% 4.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $639.0K $988.0K
YoY Change 125.8% 74.87%
Accrued Expenses $1.282M $1.688M
YoY Change -32.84% -17.94%
Deferred Revenue $3.411M $3.398M
YoY Change -3.89%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.802M $6.480M
YoY Change 1.06% 14.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $812.0K $921.0K
YoY Change -26.85% 768.87%
Total Long-Term Liabilities $5.181M $921.0K
YoY Change 366.76% 768.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.802M $6.480M
Total Long-Term Liabilities $5.181M $921.0K
Total Liabilities $10.98M $7.401M
YoY Change 60.31% 28.31%
SHAREHOLDERS EQUITY
Retained Earnings -$58.20M -$56.44M
YoY Change 3.06% 2.21%
Common Stock $98.52M $99.26M
YoY Change 0.53% 1.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.21M $42.65M
YoY Change
Total Liabilities & Shareholders Equity $51.19M $50.05M
YoY Change 5.83% 4.45%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$1.758M $2.599M
YoY Change 40.08% -264.6%
Depreciation, Depletion And Amortization $173.0K $141.0K
YoY Change 3.59% -17.54%
Cash From Operating Activities -$481.0K -$2.003M
YoY Change -52.66% 5.64%
INVESTING ACTIVITIES
Capital Expenditures $586.0K -$133.0K
YoY Change -9866.67%
Acquisitions
YoY Change
Other Investing Activities $1.251M -$10.01M
YoY Change -151.06%
Cash From Investing Activities $665.0K -$10.14M
YoY Change -127.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.092M -182.0K
YoY Change -891.3% -18300.0%
NET CHANGE
Cash From Operating Activities -481.0K -2.003M
Cash From Investing Activities 665.0K -10.14M
Cash From Financing Activities -1.092M -182.0K
Net Change In Cash -908.0K -12.33M
YoY Change -72.77% 550.5%
FREE CASH FLOW
Cash From Operating Activities -$481.0K -$2.003M
Capital Expenditures $586.0K -$133.0K
Free Cash Flow -$1.067M -$1.870M
YoY Change 5.64% -1.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29963000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21655905
dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12657000
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Amendment Flag
AmendmentFlag
false
awre Minimum Period Of Payment Of Transaction Price In Contract With Customer
MinimumPeriodOfPaymentOfTransactionPriceInContractWithCustomer
P30D
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001015739
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1909000
dei Entity File Number
EntityFileNumber
000-21129
dei Entity Registrant Name
EntityRegistrantName
AWARE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2911026
dei Entity Address Address Line1
EntityAddressAddressLine1
76 Blanchard Road in Burlington
dei Entity Address City Or Town
EntityAddressCityOrTown
Burlington
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01803
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
276-4000
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
AWRE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 us-gaap Marketable Securities
MarketableSecurities
18315000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
295000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
74000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3664000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3763000
CY2022Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3756000
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3087000
CY2022Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1411000
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1411000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1438000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
591000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
41241000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
38815000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
208000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3216000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2910000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3222000
CY2022Q3 us-gaap Goodwill
Goodwill
3120000
CY2021Q4 us-gaap Goodwill
Goodwill
3120000
CY2022Q3 us-gaap Debt Securities Noncurrent
DebtSecuritiesNoncurrent
2570000
CY2022Q3 us-gaap Assets
Assets
50049000
CY2021Q4 us-gaap Assets
Assets
48373000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
988000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
283000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1688000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21686528
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21686528
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3398000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1874000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3549000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
406000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6480000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5741000
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
408000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
191000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
513000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
919000
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
921000
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1110000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21613982
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21613982
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
217000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
216000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
99041000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
97778000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56440000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56472000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-170000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
42648000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41522000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50049000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48373000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3015000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4175000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11945000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12857000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
282000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
243000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
920000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
933000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2279000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2307000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6932000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7067000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1579000
us-gaap Net Income Loss
NetIncomeLoss
31000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1631000
us-gaap Net Income Loss
NetIncomeLoss
-4569000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5067000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4785000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1808000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1574000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4895000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4644000
CY2022Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5672000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5672000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
571000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
5755000
us-gaap Costs And Expenses
CostsAndExpenses
12142000
us-gaap Costs And Expenses
CostsAndExpenses
17429000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2444000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1580000
us-gaap Operating Income Loss
OperatingIncomeLoss
-197000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4572000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
155000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
us-gaap Investment Income Interest
InvestmentIncomeInterest
228000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2599000
us-gaap Net Income Loss
NetIncomeLoss
-4569000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21725000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21532000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21674000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21508000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21798000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21532000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21733000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21508000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-170000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-170000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2429000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1579000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-139000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4569000
us-gaap Net Income Loss
NetIncomeLoss
31000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
2500000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
587000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
520000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
441000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1579000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5672000
us-gaap Share Based Compensation
ShareBasedCompensation
1356000
us-gaap Share Based Compensation
ShareBasedCompensation
1077000
awre Accrued Interest Receivable
AccruedInterestReceivable
70000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
221000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
122000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
849000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
669000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1044000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
776000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
163000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
706000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
71000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-220000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
525000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
67000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-786000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4561000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5218000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
144000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
8547000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
18556000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12653000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
96000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
24000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
54000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
164000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-92000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-17306000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5268000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29963000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38565000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12657000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33297000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
45670000
CY2021Q1 awre Shares Surrendered To Pay Taxes Related To Unrestricted Stock Value
SharesSurrenderedToPayTaxesRelatedToUnrestrictedStockValue
54000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
197000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1448000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
44365000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
25000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
439000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1542000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
43287000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
42149000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41522000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
430000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1278000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3015000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4175000
awre Unbilled Receivables Current Revenue Recognized In Advance Of Billings
UnbilledReceivablesCurrentRevenueRecognizedInAdvanceOfBillings
3739000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
40674000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
93000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
378000
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1289000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
39853000
CY2022Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
3000
CY2022Q3 awre Shares Surrendered To Pay Taxes Related To Unrestricted Stock Value
SharesSurrenderedToPayTaxesRelatedToUnrestrictedStockValue
24000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
548000
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
161000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-170000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2599000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
42648000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11945000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12857000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:20.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="margin-left:4.4%;text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. The most significant estimates included in the financial statements pertain to revenue recognition, reserves for doubtful accounts, valuation of acquired assets and assumed liabilities in business combinations, valuation of earn-out liability, valuation of the investment in the note receivable, goodwill and long-lived asset impairment and valuation allowance for deferred income tax assets. Actual results could differ from those estimates.</span></p>
awre Maximum Period Of Payment Of Transaction Price In Contract With Customer
MaximumPeriodOfPaymentOfTransactionPriceInContractWithCustomer
P60D
CY2021Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2867000
CY2021Q3 awre Unbilled Receivables Current Revenue Recognized In Advance Of Billings
UnbilledReceivablesCurrentRevenueRecognizedInAdvanceOfBillings
1660000
CY2021Q3 awre Unbilled Receivables Current Billings
UnbilledReceivablesCurrentBillings
1255000
CY2021Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3272000
CY2022Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3430000
CY2022Q3 awre Unbilled Receivables Current Revenue Recognized In Advance Of Billings
UnbilledReceivablesCurrentRevenueRecognizedInAdvanceOfBillings
1278000
CY2022Q3 awre Unbilled Receivables Current Billings
UnbilledReceivablesCurrentBillings
952000
CY2022Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3756000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2947000
CY2021Q3 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
1725000
CY2021Q3 awre Contract With Customer Liability Revenue Recognized Additions Made During Period
ContractWithCustomerLiabilityRevenueRecognizedAdditionsMadeDuringPeriod
-1526000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3146000
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3533000
CY2022Q3 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
2059000
CY2022Q3 awre Contract With Customer Liability Revenue Recognized Additions Made During Period
ContractWithCustomerLiabilityRevenueRecognizedAdditionsMadeDuringPeriod
-1786000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3806000
CY2020Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2229000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
awre Unbilled Receivables Current Billings
UnbilledReceivablesCurrentBillings
2696000
CY2021Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3272000
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3087000
awre Unbilled Receivables Current Revenue Recognized In Advance Of Billings
UnbilledReceivablesCurrentRevenueRecognizedInAdvanceOfBillings
4279000
awre Unbilled Receivables Current Billings
UnbilledReceivablesCurrentBillings
3610000
CY2022Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3756000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3933000
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
4043000
awre Contract With Customer Liability Revenue Recognized Additions Made During Period
ContractWithCustomerLiabilityRevenueRecognizedAdditionsMadeDuringPeriod
-4830000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3146000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3740000
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
5333000
awre Contract With Customer Liability Revenue Recognized Additions Made During Period
ContractWithCustomerLiabilityRevenueRecognizedAdditionsMadeDuringPeriod
-5267000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3806000
awre Percentage Of Remaining Performance Obligations Expected To Be Recognized As Revenue
PercentageOfRemainingPerformanceObligationsExpectedToBeRecognizedAsRevenue
0.67
awre Minimum Period Of Remaining Performance Obligations
MinimumPeriodOfRemainingPerformanceObligations
P12M
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2300000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12700000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30000000.0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
18485000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
175000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18315000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2599000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1579000
us-gaap Net Income Loss
NetIncomeLoss
31000
CY2022Q3 us-gaap Purchase Obligation
PurchaseObligation
8900000
CY2022Q3 awre Brokerage Commission Paid
BrokerageCommissionPaid
300000
CY2022Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
2900000
CY2022Q3 awre Remaining Depreciation On Assets Held For Sale
RemainingDepreciationOnAssetsHeldForSale
1800000
CY2022Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5700000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3420000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
510000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2910000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
44000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
103000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
415000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
415000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
412000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
412000
CY2022Q3 awre Finite Lived Intangible Assets Amortization Expense Rolling After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFour
1153000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2910000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Net Income Loss
NetIncomeLoss
-4569000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21725000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21532000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21674000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21508000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
73000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
59000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21798000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21532000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21733000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21508000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
548000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
441000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1356000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1077000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 awre Estimated Benefit Amount Federal Tax Refund Receivable
EstimatedBenefitAmountFederalTaxRefundReceivable
1400000

Files In Submission

Name View Source Status
0000950170-22-020458-index-headers.html Edgar Link pending
0000950170-22-020458-index.html Edgar Link pending
0000950170-22-020458.txt Edgar Link pending
0000950170-22-020458-xbrl.zip Edgar Link pending
awre-20220930.htm Edgar Link pending
awre-20220930.xsd Edgar Link pending
awre-ex31_1.htm Edgar Link pending
awre-ex31_2.htm Edgar Link pending
awre-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
awre-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
awre-20220930_pre.xml Edgar Link unprocessable
awre-20220930_lab.xml Edgar Link unprocessable
awre-20220930_def.xml Edgar Link unprocessable
awre-20220930_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending